Check out your Company Bowl for anonymous work chats.
Otsuka’s JYNARQUE™ (tolvaptan) Approved by U.S. FDA as the First Treatment to Slow Kidney Function Decline in Adults at Risk of Rapidly Progressing Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Otsuka's JYNARQUE™ (tolvaptan) Approved by U.S. FDA as the First Treatment to Slow Kidney Function Decline in Adults at Risk of Rapidly Progressing Autosomal Dominant Polycystic Kidney Disease (ADPKD) | Discover Otsuka
Otsuka Encourages Start-Ups to Spark the Next Generation of Innovation and Collaboration in Mental Health Care
Otsuka Encourages Start-Ups to Spark the Next Generation of Innovation and Collaboration in Mental Health Care | Discover Otsuka
Otsuka Awarded Grant to Advance Development of Novel Anti-Tuberculosis Compound OPC-167832 with Delamanid
Otsuka Awarded Grant to Advance Development of Novel Anti-Tuberculosis Compound OPC-167832 with Delamanid | Discover Otsuka
http://glassdoor.com/slink.htm?key=vQg4u
Science 37 and Otsuka Pharmaceutical Collaborate to Advance Digital Health Innovation with Focus on Technology-Enabled Clinical Trials at Home | Discover Otsuka
Otsuka And Proteus® Announce The First U.S. FDA Approval of A Digital Medicine System: ABILIFY MYCITE® (aripiprazole tablets with sensor)
Otsuka And Proteus ® Announce The First U.S. FDA Approval of A Digital Medicine System: ABILIFY MYCITE ® (aripiprazole tablets with sensor) | Discover Otsuka
FDA Accepts Otsuka’s Resubmission To Support A Regulatory Review Of Tolvaptan In The Treatment Of ADPKD
FDA Accepts Otsuka's Resubmission To Support A Regulatory Review Of Tolvaptan In The Treatment Of ADPKD | Discover Otsuka
Science 37 and Otsuka Pharmaceutical Collaborate to Advance Digital Health Innovation with Focus on Technology-Enabled Clinical Trials at Home
Science 37 and Otsuka Pharmaceutical Collaborate to Advance Digital Health Innovation with Focus on Technology-Enabled Clinical Trials at Home | Discover Otsuka
Otsuka and Proteus Digital Health® Resubmit Application to FDA For First Digital Medicine
Otsuka and Proteus Digital Health® Resubmit Application to FDA For First Digital Medicine | Discover Otsuka
PRESS RELEASES 25 APR 2017: Akebia and Otsuka Expand Relationship with Collaboration to Develop and Commercialize Vadadustat in Europe, China and Other Territories.
Akebia and Otsuka Expand Relationship with Collaboration to Develop and Commercialize Vadadustat in Europe, China and Other Territories | Discover Otsuka
PRESS RELEASES 02 MAY 2017: Otsuka and Lundbeck announce results of brexpiprazole on symptoms of agitation related to Alzheimer’s-type dementia.
Otsuka and Lundbeck announce results of brexpiprazole on symptoms of agitation related to Alzheimer's-type dementia | Discover Otsuka